FDA-Drug2026-07-29Class IICHEMICAL
Major Pharmaceuticals Levothyroxine Sodium 112 mcg tablets recalled for subpotency
LABEL MIX UPNationwide distribution
Major Pharmaceuticals Levothyroxine 112 mcg recalled for subpotency
Major Pharmaceuticals issued a recall of Levothyroxine Sodium 112 mcg tablets (Lot #N02203, expiring 09/2026) because the medication is subpotent—meaning it contains less active ingredient than labeled. Patients taking this lot may not receive the full intended dose of this thyroid replacement medication.
- Check if you have this medication (NDC 0904-6954-61, Lot #N02203).
- Contact your pharmacy or doctor if you have this lot—do not stop taking levothyroxine without medical guidance.
- Your doctor may need to verify your dose or replace your supply.
Hazard
Subpotent Drug
Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6954-61
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0704-2026More Major Pharmaceuticals recalls
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 75 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine sodium 150 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine 75 mcg tablets recalled for subpotent drug
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 125 mcg tablets recalled for subpotency
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief